Metathesis process

US9604903B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9604903-B2
Application numberUS-201314383348-A
CountryUS
Kind codeB2
Filing dateMar 18, 2013
Priority dateMar 18, 2012
Publication dateMar 28, 2017
Grant dateMar 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process of metathesizing a feedstock in the presence of a metathesis catalyst and at least one catalyst enhancer. The catalyst enhancer can be selected from a sacrificial catalyst or a non-catalyst enhancer. The process exhibits improved reaction times and/or the metathesis catalyst can be used at very low concentrations.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture, wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer, wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II), dichloro-(3-phenyl-1H-inden-1-ylidene)bis(isobutylphobane)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(pyridyl)ruthenium(II), [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(4-methylphenyl)imino]methyl]-4-nitro-phenolyl]chloro-[3-phenyl-indenylidene]ruthenium(II), and [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(2-methylphenyl)imino]methyl]-phenolyl]chloro-(3-phenyl-indenylidene)ruthenium(II), wherein the non-catalyst enhancer is selected from the group consisting of a Lewis acid and a titanium based compound, wherein the process is carried out without a solvent or in a solvent consisting of hydrocarbons and/or alcohols, wherein the metathesis catalyst efficiency is less than 100. 2. The process according to claim 1 wherein at least 40 wt. % of the feedstock is metathesized. 3. The process according to claim 1 wherein the process reaches equilibrium in less than 20 minutes. 4. The process according to claim 1 wherein the metathesis catalyst is present in an amount less than 100 ppm with respect to the reaction mixture. 5. The process according to claim 4 wherein the metathesis catalyst is present in an amount less than 10 ppm with respect to the reaction mixture. 6. The process according to claim 1 wherein the metathesis catalyst efficiency is less than 10. 7. The process according to claim 1 wherein the metathesis catalyst retains over 75% of its activity after 30 minutes. 8. The process according to claim 1 wherein no chemical treatment of the feedstock or starting material to remove catalyst poisons is performed. 9. The process according to claim 1 wherein the sacrificial catalyst is a sacrificial metathesis catalyst different from the metathesis catalyst. 10. The process according to claim 1 wherein the sacrificial catalyst is present in an amount ranging from 1 ppm to 100 ppm with respect to the reaction mixture. 11. The process according to claim 1 wherein the non-catalyst enhancer is a Lewis acid. 12. The process according to claim 1 wherein the non-catalyst enhancer is a titanium based compound. 13. The process according to claim 1 wherein the non-catalyst enhancer is selected from the group consisting of titanium (IV) methoxide, titanium (IV) ethoxide, titanium (IV) propoxide, titanium (IV) isopropoxide, titanium (IV) butoxide, titanium (IV) tert-butoxide, titanium (IV) 2-ethylhexoxide, titanium (IV) 2-ethyl-1,3-hexanediolate, titanium (IV) tetrachloride, titanium (IV) tetrabromide, titanium (IV) tetrafluoride, titanium (IV) tetraiodide, and mixtures thereof. 14. The process according to claim 1 wherein the non-catalyst enhancer is present in an amount ranging from 10 ppm to 1,000 ppm with respect to the reaction mixture. 15. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture, wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer, wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II), dichloro-(3-phenyl-1H-inden-1-ylidene)bis(isobutylphobane)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(pyridyl)ruthenium(II), [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(4-methylphenyl)imino]methyl]-4-nitro-phenolyl]chloro-[3-phenyl-indenylidene]ruthenium(II), and [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(2-methylphenyl)imino]methyl]-phenolyl]chloro-(3-phenyl-indenylidene)ruthenium(II), wherein the non-catalyst enhancer is selected from the group consisting of copper iodide, sodium iodide, tetrabutylgermanium, tetraethylsilicon, tin oxide, tin octoate, tin oxalate, dibutyltin dilaurate, tin(IV) chloridetetrabutyl orthotitanate, palladium acetate, tris(dibenzylideneacetone)palladium, tetrakis(triphenylphosphine)palladium, bis(diphenylferrocenyl)palladium dichloride, nickel chloride, bis(cyclooctadiene)nickel, nickelocene iron chloride, iron bromide, ferrocene, silver chloride, silver iodide, silver oxide, iodine, silver trifluoromethanesulfonate, sodium borohydride, boric acid, zinc ethylhexanoate, zircon (IV) oxide chloride octahydrate, acetic acid, butylated hydroxytoluene (BHT), quinones, activated charcoal, alumina, bleaching earth, titanium compounds having the general formula Ti.[Q] 4 wherein each Q independently represents hydrogen, a C 1 to C 10 alkoxy group, a C 4 to C 8 aryl group, a C 12 to C 18 fatty alcohol, or a C 6 to C 18 fatty acid, wherein the non-catalyst enhancer is present in an amount ranging from 10 ppm to 1,000 ppm with respect to the reaction mixture. 16. The process according to claim 15 wherein the metathesis catalyst is present in an amount less than 100 ppm with respect to the reaction mixture. 17. The process according to claim 15 wherein the metathesis catalyst efficiency is less than 100. 18. The process according to claim 15 wherein no chemical treatment of the feedstock or starting material to remove catalyst poisons is performed. 19. The process according to claim 15 wherein the sacrificial catalyst is present in an amount ranging from 1 ppm to 100 ppm with respect to the reaction mixture. 20. The process according to claim 15 wherein the non-catalyst enhancer is a titanium compound having the general formula Ti.[Q] 4 wherein each Q independently represents hydrogen, a C 1 to C 10 alkoxy group, a C 4 to C 8 aryl group, a C 12 to C 18 fatty alcohol, or a C 6 to C 18 fatty acid. 21. The process according to claim 15 wherein the non-catalyst enhancer is selected from the group consisting of titanium (IV) methoxide, titanium (IV) ethoxide, titanium (IV) propoxide, titanium (IV) isopropoxide, titanium (IV) butoxide, titanium (IV) tert-butoxide, titanium (IV) 2-ethylhexoxide, titanium (IV) 2-ethyl-1,3-hexanediolate, and mixtures thereof. 22. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture, wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer, wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II)

Assignees

Inventors

Classifications

  • B01J31/128Primary

    Mixtures of organometallic compounds · CPC title

  • Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts · CPC title

  • by splitting of esters · CPC title

  • of vegetal origin · CPC title

  • Ruthenium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9604903B2 cover?
A process of metathesizing a feedstock in the presence of a metathesis catalyst and at least one catalyst enhancer. The catalyst enhancer can be selected from a sacrificial catalyst or a non-catalyst enhancer. The process exhibits improved reaction times and/or the metathesis catalyst can be used at very low concentrations.
Who is the assignee on this patent?
Croda Int Plc
What technology area does this patent fall under?
Primary CPC classification B01J31/128. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).